Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
Hans‐Georg Rammensee, Cécile Gouttefangeas, Sonja Heidu, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 428-428
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
Rhia Kundu, Janakan Sam Narean, Lulu Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 292
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler, et al.
Nature (2021) Vol. 601, Iss. 7894, pp. 617-622
Open Access | Times Cited: 211
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2
Grigoris D. Amoutzias, Marios Nikolaidis, Eleni Tryfonopoulou, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 82
Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
Jingxing Yang, Jen‐Chih Tseng, Guann‐Yi Yu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 423-423
Open Access | Times Cited: 80
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 30
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Jens Bauer, Natalie Köhler, Yacine Maringer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity
Jonah Lin, Ryan Law, Chapin S. Korosec, et al.
Journal of Virology (2022) Vol. 96, Iss. 13
Open Access | Times Cited: 30
Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019
Jiayu Dai, Yibo Wang, Hongrui Wang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
Jonas S. Heitmann, Claudia Tandler, Maddalena Marconato, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
Dubravko Forčić, Karmen Mršić, Melita Perić Balja, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 958-958
Open Access | Times Cited: 4
Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection
Dian Ayu Eka Pitaloka, Afifah Izzati, Siti Amirah, et al.
Advances and Applications in Bioinformatics and Chemistry (2022) Vol. Volume 15, pp. 43-57
Open Access | Times Cited: 14
A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2
Xiaoxiao Jin, Xiaotao Liu, Chuanlai Shen
Virus Research (2022) Vol. 324, pp. 199024-199024
Open Access | Times Cited: 13
Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences
Maria Madeleine Rüthrich, Nicola Giesen, Sibylle C. Mellinghoff, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 182-182
Open Access | Times Cited: 12
Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice
Anran Shen, Xiaoxiao Jin, Tao‐Tao Tang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3325-3341
Open Access | Times Cited: 11
Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
Amir Ghaemi, Parisa Roshani Asl, Hedieh Zargaran, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
AI Aided Design of Epitope-Based Vaccine for the Induction of Cellular Immune Responses Against SARS-CoV-2
Giovanni Mazzocco, Iga Niemiec, Alexander Myronov, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 14
Simultaneous Identification of Functional Antigen-Specific CD8+ and CD4+ Cells after In Vitro Expansion Using Elongated Peptides
J. Schuhmacher, Leon Kleemann, Jennifer R. Richardson, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3451-3451
Open Access | Times Cited: 9
Designing a novel multi-epitopes pan-vaccine against SARS-CoV-2 and seasonal influenza: in silico and immunoinformatics approach
Matin Fathollahi, Hamid Motamedi, Hadi Hossainpour, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 20, pp. 10761-10784
Closed Access | Times Cited: 3
Toll-Like Receptors and Emerging Viral Infections
Muhammad Luqman, Sahibzada Nawazash Ali, Zainab Khalid, et al.
IntechOpen eBooks (2024)
Open Access
Activating the leukocytes by short synthetic peptides in vitro as a stage in the creation of treatment-prophylactic vaccines against COVID-19
A. M. Tsygankov, О. V. Gribovskaya, В. П. Мартинович, et al.
Proceedings of the National Academy of Sciences of Belarus Medical series (2024) Vol. 21, Iss. 1, pp. 53-61
Open Access
The presenting HLA determines fidelity of SARS-CoV-2 spike protein epitope prediction
Charles R. Schutt, Deren Birol, Xiuyuan Lu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
PCI-DB: A novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development
Steffen Lemke, Marissa L. Dubbelaar, Petra Zimmermann, et al.
Research Square (Research Square) (2024)
Open Access
Longitudinal Assessment of SARS-CoV-2 Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multi-Cytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity
Jonah Lin, Ryan Law, Chapin S. Korosec, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Claudia Tandler, Jonas S. Heitmann, Tanja Michel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top